Cargando…
Infections with the SARS-CoV-2 Omicron variant show a similar outcome as infections with the previous variants in patients with hematologic malignancies
Autores principales: | Taenaka, Ryutaro, Obara, Teppei, Kohno, Kentaro, Aoki, Kenichi, Ogawa, Ryosuke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989258/ https://www.ncbi.nlm.nih.gov/pubmed/35391563 http://dx.doi.org/10.1007/s00277-022-04833-8 |
Ejemplares similares
-
Predictors of the Overall Survival with Azacitidine Monotherapy in Untreated Acute Myeloid Leukemia Patients Ineligible for Intensive Therapy
por: Taenaka, Ryutaro, et al.
Publicado: (2022) -
Successful treatment with daratumumab, lenalidomide, and dexamethasone therapy followed by autologous stem cell transplantation for newly diagnosed polyneuropathy, organomegaly, endocrinopathy, M-protein, skin changes syndrome: a case report
por: Taenaka, Ryutaro, et al.
Publicado: (2022) -
Reduction in the infection fatality rate of Omicron variant compared with previous variants in South Africa
por: Liu, Yuan, et al.
Publicado: (2022) -
Previous omicron infection may be protective against reinfection with omicron variant BA.5 for at least 5 months
por: Koga, Michiko, et al.
Publicado: (2023) -
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)